Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid. 

 

There are currently no ongoing consultations.
 
0101-01 Initial Sodium dichromate 234-190-3
7789-12-0
10588-01-9
Airbus Helicopters Technik GmbH [name of applicant in the original application: “ZF Luftfahrttechnik GmbH” updated due to a notified corporate name change] Use of Sodium dichromate for surface treatment of metals such as aluminium, steel, zinc, magnesium, titanium, alloys, composites, sealings of anodic films Commission decided Details
0102-01 Initial Chromium trioxide 215-607-8 1333-82-0 Clariant Produkte (Deutschland) GmbH Use of chromium trioxide in a catalyst for the dehydrogenation of propane to propene Commission decided Details
0103-01 Initial Chromium trioxide 215-607-8 1333-82-0 Euro Cryospace France The use of chromium trioxide for the surface preparation of aluminium alloy cryogenic tanks used in the Ariane 5 launcher Commission decided Details
0104-01 Initial Sodium dichromate 234-190-3
7789-12-0
10588-01-9
Borealis Plastomers B.V. The use of sodium dichromate as in-situ corrosion inhibitor in a closed water/ammonia absorption cooling system Commission decided Details
0105-01 Initial Sodium dichromate 234-190-3
7789-12-0
10588-01-9
ILARIO ORMEZZANO - SAI s.r.l. [name of applicant in the original application: Ilario Ormezzano Sai Spa updated due to a notified name change] Repackaging of Sodium Dichromate to be supplied as a mordant in the dyeing of wool as sliver and/or yarn with dark colours in industrial settings Opinions adopted Details
0105-02 Initial Sodium dichromate 234-190-3
7789-12-0
10588-01-9
ILARIO ORMEZZANO - SAI s.r.l. [name of applicant in the original application: Ilario Ormezzano Sai Spa updated due to a notified name change] Use of Sodium Dichromate as a mordant in the dyeing of wool as sliver and/or yarn with dark colours in industrial settings Opinions adopted Details
0106-01 Initial Ammonium dichromate 232-143-1 7789-09-5 BAE Systems (Operations) Limited – [Decision discontinued as of 01/01/2021]
Qioptiq Ltd – [Decision discontinued as of 01/01/2021]
Industrial use of Ammonium Dichromate in the process of manufacturing holographic combiners for diffractive head-up displays intended to be used in military aircrafts Discontinued as of 01 January 2021 Details
0106-02 Initial Ammonium dichromate 232-143-1 7789-09-5 Display Technologies Limited - [Decision discontinued as of 01/01/2021] Industrial use of Ammonium Dichromate in the process of manufacturing Cathode Ray Tubes for head up displays intended to be used in military and civilian aircrafts Discontinued as of 01 January 2021 Details
0107-01 Initial 1,2-Dichloroethane (EDC) 203-458-1 107-06-2 emp Biotech GmbH Use as a solvent in manufacture of polymeric particles for pharmaceutical and research purification processes Commission decided Details
0108-01 Initial 1,2-Dichloroethane (EDC) 203-458-1 107-06-2 ORGAPHARM Use as a process solvent in the manufacture of an Active Pharmaceutical Ingredient: Flecainide acetate Commission decided Details